autologous dexosomes loaded with tumor-specific peptides

SUSPENDED · PHASE2 · Melanoma

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.